Clinical trial
Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic…
NCT00096785 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00096785 |
|---|---|
| Title | Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection |
| Official title | Randomized, Open-Label, Comparative Study to Evaluate Early Viral Load Reductions and Exploratory Viral Kinetics Following Administration of Entecavir or Adefovir in Nucleoside-Naive Adults With Chronic Hepatitis B Infection |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis B, Chronic Disease |
| Intervention type | Drug |
| Interventions | entecavir, adefovir |
| Enrollment | 69 |
| Start date | Dec 1, 2004 |
| Primary completion | Jan 1, 2006 |
| Completion | Apr 1, 2008 |
| First posted | Nov 16, 2004 |
| Last update posted | Aug 10, 2010 |
| Countries | Canada, Hong Kong, Indonesia, Philippines, Singapore, Taiwan, Thailand, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: